Supreme Court of the United States
Skip Navigation LinksHome | Search Results

        

Docket for 12-245
No. 12-245
Vide 12-265
Title:
Merck & Co., Inc., Petitioner
v.
Louisiana Wholesale Drug Company, Inc., et al.
Docketed:August 24, 2012
Lower Ct:United States Court of Appeals for the Third Circuit
  Case Nos.:(10-2077, 10-2078, 10-2079, 10-4571)
  Decision Date:July 16, 2012

~~~Date~~~ ~~~~~~~Proceedings  and  Orders~~~~~~~~~~~~~~~~~~~~~
Aug 24 2012 Petition for a writ of certiorari filed. (Response due September 24, 2012)
Sep 6 2012 Order extending time to file response to petition to and including October 24, 2012, for all respondents.
Sep 10 2012 Consent to the filing of amicus curiae briefs in support of either party or neither party received from counsel for the petitioner.
Sep 24 2012 Brief amicus curiae of Pharmaceutical Research and Manufacturers of America (PhRMA) filed.
Sep 24 2012 Brief amicus curiae of Washington Legal Foundation filed. VIDED.
Sep 24 2012 Brief amicus curiae of New York Intellectual Property Law Association filed. VIDED.
Sep 24 2012 Appendix of amicus New York Intellectual Property Law Association filed. VIDED.
Sep 24 2012 Brief amici curiae of Bayer AG & Bayer Corp. filed. VIDED.
Oct 12 2012 Order further extending time to file response to petition to and including November 5, 2012.
Oct 31 2012 Order further extending time to file response to petition to and including November 7, 2012.
Nov 7 2012 Brief of respondents Louisiana Wholesale Drug Company, Inc., et al. in opposition filed. VIDED.
Nov 20 2012 DISTRIBUTED for Conference of December 7, 2012.
Nov 20 2012 Reply of petitioner Merck & Co., Inc. filed. (Distributed)
Jun 17 2013 DISTRIBUTED for Conference of June 20, 2013.
Jun 18 2013 Supplemental brief of petitioner Merck & Co., Inc. filed. (Distributed)
Jun 19 2013 Supplemental brief of respondents Louisiana Wholesale Drug Company, Inc., et al. filed. VIDED. (Distributed)
Jun 24 2013 Petition GRANTED. Judgment VACATED and case REMANDED for further consideration in light of FTC v. Actavis, Inc., 570 U.S. ___ (2013). Justice Alito took no part in the consideration or decision of this petition.
Jul 26 2013 JUDGMENT ISSUED.



~~Name~~~~~~~~~~~~~~~~~~~~~    ~~~~~~~Address~~~~~~~~~~~~~~~~~~   ~~Phone~~~
Attorneys for Petitioner:
Kannon K. Shanmugam Williams & Connolly LLP(202) 434-5000
725 Twelfth Street, N.W.
Washington, DC  20005
kshanmugam@wc.com
Party name: Merck & Co., Inc.
Attorneys for Respondents:
Thomas C. Goldstein Goldstein & Russell, P.C.(202) 362-0636
    Counsel of Record5225 Wisconsin Avenue, N.W., Suite 404
Washington, DC  20015
tg@goldsteinrussell.com
Party name: Louisiana Wholesale Drug Company, Inc., et al.
Other:
Steven G. Bradbury Dechert LLP(202) 261-3483
1900 K Street, N.W.
Washington, DC  20006
steven.bradbury@dechert.com
Party name: Washington Legal Foundation
 
Douglas Hallward-Driemeier Ropes & Gray LLP(202) 508-4600
One Metro Center
700 12th Street, NW, Suite 900
Washington, DC  20005
Douglas.Hallward-Driemeier@ropesgray.com
Party name: Pharmaceutical Research and Manufacturers of America (PhRMA)
 
Charles E. Miller Sills Cummis & Gross LLP(212) 643-7000
Rockefeller Center - GE Building, 29th Floor
30 Rockefeller Plaza
New York, NY  10112
cmiller@sillscummis.com
Party name: New York Intellectual Property Law Association
 
Lawrence D. Rosenberg Jones Day(202) 879-3939
51 Louisiana Avenue, NW
Washington, DC  20001
ldrosenberg@jonesday.com
Party name: Bayer AG & Bayer Corp.
November 24, 2014 | Version 2014.1